PO.PS01.04 · 人群科学

冈比亚女性乳腺癌患者获得医疗服务的障碍与促进因素特征分析

Characterizing barriers and facilitators to healthcare access among female breast cancer patients in The Gambia

海报缩略图:冈比亚女性乳腺癌患者获得医疗服务的障碍与促进因素特征分析
编号 902 展板 15 时间 4/19 02:00–05:00 区域 Section 35 主讲 Anjali Gupta, BS
分会场 Survivorship Research Addressing Cancer Disparities
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Anjali Gupta1, Jen Gathings2, Ami Mejia2, Ramatoulie Jobe3, Anna Korrea3, Abdul K. Fye3, Joseph W. Jatta3, Ashwini Joshi4, Ousman Sanyang3, Alagie Manneh3, Charles A. P. Roberts3, Lamin Jaiteh3, Gabriel O. Ogun3, Tomi F. Akinyemiju4

1School of Medicine, Stanford University, Stanford, CA,2ETR Services, LLC, Durham, CA,3School of Medicine & Allied Health Sciences, University of The Gambia, Banjul, Gambia,4School of Medicine, Duke University, Durham, NC

摘要 Abstract

中文摘要
背景:冈比亚是非洲大陆面积最小的国家,据估计其癌症生存率在非洲、亚洲和中美洲各国中位居最低之列。尽管医疗可及性差是冈比亚乳腺癌生存率低的原因之一,但对于患者在医疗可及性多个维度上的经历知之甚少。本研究旨在刻画乳腺癌诊疗中医疗可及性的障碍与促进因素。 方法:来自冈比亚班珠尔市Edward Francis Small教学医院(EFSTH;该国最大的转诊中心)的23名乳腺癌患者于2023年6月至12月参与了半结构化访谈。访谈酌情以沃洛夫语、曼丁哥语和/或英语进行。主题包括患者的经历与确诊路径、既往对乳腺癌的认知与观念、获得诊疗的障碍以及影响治疗历程的文化因素。分析将归纳法与遵循Penchansky和Thomas(1981年)医疗可及性理论框架的初步演绎法相结合,最终形成一套编码。 结果:在21名有年龄数据的参与者中,平均(SD)年龄为44(10)岁。大多数参与者在确诊前对乳腺癌几乎一无所知。从症状出现到确诊的时间跨度很大,从几周到数月或数年不等。7名参与者(30%)报告在就诊于医疗专业人员之前曾使用传统医药。诊断程序和治疗的可负担性是被提及最多的障碍(91%的参与者),其次是服务的可获得性(如医疗提供者、可用设备、机构开展诊疗的能力、药物等;83%)、医疗提供者的可及性(距离与交通;74%)、与患者偏好相关的适配性(卫生系统的组织安排;43%),以及可接受性(医患互动的质量;9%)。家人、同伴和信仰是癌症历程中重要的支持与慰藉来源。 结论:我们的结果凸显了冈比亚乳腺癌患者在获得医疗服务方面的主要障碍,这些障碍导致了诊断和治疗的延迟。采取多层次举措以应对这些障碍,对于减轻该国乳腺癌负担至关重要。
查看英文原文 English abstract
Background: The Gambia, the smallest country within mainland Africa, is estimated to have one of the lowest cancer survival rates of countries in Africa, Asia, and Central America. Although poor access to healthcare contributes to low breast cancer survival rates in The Gambia, little is known about patient experiences across multiple healthcare access domains. The purpose of this study was to characterize healthcare access barriers and facilitators to breast cancer care. Methods: Twenty-three breast cancer patients from the Edward Francis Small Teaching Hospital (EFSTH; largest referral center in the country) in Banjul, The Gambia participated in semi-structured interviews from June-December 2023. Interviews were conducted in Wolof, Mandinka and/or English as appropriate. Topics included patient experiences and pathways to diagnosis, prior knowledge and beliefs about breast cancer, barriers to accessing care, and cultural factors impacting the treatment journey. Analysis coupling an inductive approach with an initial deductive approach following Penchansky and Thomas's (1981) theoretical framework of healthcare access resulted in a final set of codes. Results: Of the 21 participants with available age data, the mean (SD) age was 44 (10) years. Most participants had little to no knowledge of breast cancer prior to their diagnosis. The time from symptom onset to diagnosis ranged widely from a few weeks to months or years. Seven participants (30%) reported using traditional medicine prior to visiting a healthcare professional. Affordability of diagnostic procedures and treatments was the most frequently mentioned barrier (91% of participants), followed by availability of services (e.g., providers, working equipment, facilities' capacities to perform procedures, medications, etc.; 83%), accessibility (distance and travel) of providers (74%), accommodation (health system organization) in relation to the preferences of the patients (43%), and acceptability (quality of patient-provider interaction; 9%). Family, peers, and faith were important sources of support and comfort during the cancer journey. Conclusions: Our results highlight major barriers to healthcare access among breast cancer patients in The Gambia, leading to delays in diagnosis and treatment. Multi-level initiatives to address these barriers will be crucial to reducing the breast cancer burden within the country.
利益披露 Disclosure
A. Gupta, None.. J. Gathings, None.. A. Mejia, None.. R. Jobe, None.. A. Korrea, None.. A. K. Fye, None.. J. W. Jatta, None.. A. Joshi, None.. O. Sanyang, None.. A. Manneh, None.. C. A. P. Roberts, None.. L. Jaiteh, None.. G. O. Ogun, None.. T. F. Akinyemiju, None.

← 返回 AACR 2026 检索